Immunologic Methods in Diagnosis of HIV Infection. Tehran Medical Sciences Branch, Islamic Azad

Similar documents
Retroviruses (family Retroviridae) are enveloped, single stranded (+) RNA viruses. members that are oncogenic, are associated

HIV Diagnostic Testing

SP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia

Human Immunodeficiency Virus

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

Module 3: Overview of HIV Testing Technologies

Diagnostic Tests for HIV

Fig. 1: Schematic diagram of basic structure of HIV

HIV Guideline Sakchai Dettrairat

HIV INFECTION: An Overview

Virology Introduction. Definitions. Introduction. Structure of virus. Virus transmission. Classification of virus. DNA Virus. RNA Virus. Treatment.

HIV & AIDS: Overview

HIV Testing Technology and the Latest Algorithm

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Prokaryotic Biology. VIRAL STDs, HIV-1 AND AIDS

Immunodeficiency. (2 of 2)

HIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC)

HIV testing has significantly improved

A Summary of Clinical Evidence

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS

The Alphabet Soup of Viral Hepatitis Testing

Retroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase.

New HIV Tests and Algorithm: A change we can believe in

Complicated viral infections

HIV/AIDS. Biology of HIV. Research Feature. Related Links. See Also

Diagnosis of HIV-1 Infection in Children Younger Than 18 Months in the United States

Advantages and disadvantages of different types of FDA-approved HIV immunoassays used for screening by generation and platform*

, virus identified as the causative agent and ELISA test produced which showed the extent of the epidemic

Under the Radar Screen: How Bugs Trick Our Immune Defenses

1 st and 2 nd Generation EIA

MedChem 401~ Retroviridae. Retroviridae

Julianne Edwards. Retroviruses. Spring 2010


VIROLOGY. Engineering Viral Genomes: Retrovirus Vectors

List the steps in the fourth generation HIV screening algorithm Describe the relationship between rapid HIV antibody tests and the fourth generation

Objectives. Seven days of separation. Clinical situation a transplant. The Donor COOMBS MD PHD 1. Laboratory Diagnosis & Monitoring of HIV Infection

HIV Test Technologies, Best Practices, and New Algorithm. Jenny R. McFarlane DSHS HIV Prevention and Care Branch

Supplementary Online Content

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere HIV Combo WHO reference number: PQDx

Lentiviruses: HIV-1 Pathogenesis

Trends in molecular diagnostics

Structure of HIV. Virion contains a membrane envelope with a single viral protein= Env protein. Capsid made up of Gag protein

RNA PCR, Proviral DNA and Emerging Trends in Infant HIV Diagnosis

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

HIV 101: Fundamentals of HIV Infection

19/06/2013. Viruses are not organisms (do not belong to any kingdom). Viruses are not made of cells, have no cytoplasm, and no membranes.

Viruses. Picture from:

Recombinant Protein Expression Retroviral system

The Challenges in Developing and Commercializing HIV Tests that are Useful in Differentiating VISP/R VISP/R Workshop Bethesda, MD March 2013

Viral vectors. Part I. 27th October 2014

Centers for Disease Control August 9, 2004

Obstetrics and HIV An Update. Jennifer Van Horn MD University of Utah

Evolution of HIV Diagnostics. Goals for the 2010 Conference. Bernard M. Branson, M.D. CDC Division of HIV/AIDS Prevention

HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM. Version

Adventures in Discordance- HIV Testing

Mayo Clinic HIV ecurriculum Series Essentials of HIV Medicine Module 2 HIV Virology

Identification of Microbes Lecture: 12

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

Medical Virology. Herpesviruses, Orthomyxoviruses, and Retro virus. - Herpesviruses Structure & Composition: Herpesviruses

Viral Genetics. BIT 220 Chapter 16

How HIV Causes Disease Prof. Bruce D. Walker

WHY? Viruses are considered non-living because they do:

HIV Immunopathogenesis. Modeling the Immune System May 2, 2007

HIV-1 p24 ELISA Pair Set Cat#: orb54951 (ELISA Manual)

A PROJECT ON HIV INTRODUCED BY. Abdul Wahab Ali Gabeen Mahmoud Kamal Singer

Viral Hepatitis Diagnosis and Management

Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES

Viral hepatitis Blood Born hepatitis. Dr. MONA BADR Assistant Professor College of Medicine & KKUH

Disorders Associated with the Immune System

Susanne Norris Zanto, MPH, MLS (ASCP) CM, SM Montana Public Health Laboratory

HBV : Structure. HBx protein Transcription activator

Viral hepatitis. The word hepatitis means inflammation of the liver. There are five main types of viral hepatitis: A, B, C, D, E

Hiv diagnosis By: k. baesi


The Latest in HIV Tests: What Do the Results Mean?

11/15/2011. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Viral Genomes. Structural Features and Characteristics

Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems

19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics

Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics

Human Immunodeficiency Virus type 1 (HIV-1) p24 / Capsid Protein p24 ELISA Pair Set

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Murex HIV Ag/Ab Combination Number: PQDx

VIRUSES. 1. Describe the structure of a virus by completing the following chart.

: New graphic materials for bioelisa and bioblot product lines

HIV-1/2 Ab ELISA Kit. Catalog Number KA assays Version: 12. Intended for research use only.

HEPATITIS VIRUSES. Other causes (not exclusively hepatitis v.)also called sporadic hepatitis: HEPATITIS A(infectious hepatitis)

Chapter 08 Lecture Outline

BIT 120. Copy of Cancer/HIV Lecture

New Generation of Nucleic Acid Testing. Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention

Virology and HIV. Protease Inhibitors: Another Class of Drugs Against HIV

L I F E S C I E N C E S

Running Head: AN UNDERSTANDING OF HIV- 1, SYMPTOMS, AND TREATMENTS. An Understanding of HIV- 1, Symptoms, and Treatments.

Antiviral Drugs Lecture 5

HIV and drug resistance Simon Collins UK-CAB 1 May 2009

Transcription:

Immunologic Methods in Diagnosis of HIV Infection M Parsania, Ph.D. Tehran Medical Sciences Branch, Islamic Azad University

Retroviridae Retroviruses (family Retroviridae) id ) are enveloped, single stranded d (+) RNA viruses that replicate through a DNA intermediate using reverse transcriptase. This large and diverse family includes members that are oncogenic, are associated with a variety of immune system disorders, and cause degenerative and neurological syndromes.

Retrovirus Classification Family: Retroviridae Genus Features Examples 1. Alpharetrovirus Simple, Onco Avian leucosis virus, RSV 2. Betaretrovirus Simple, Mouse Mammary Tumor Onco Virus 3. Gammaretrovirus Simple, Onco Murine leukemia virus (Moloney, Harvey) 4. Deltaretrovirus Complex, Onco 5. Epsilonretrovirus Complex, Onco Bovine Leukemia, Human T Cell Leukemia (HTLV) Walleye Dermal Sarcoma 6. Lentivirus Complex HIV, Visna, EIAV 7. Spumavirus Complex Simian Foamy Virus

RNA virus, 120nm in diameter Envelope gp160; gp120 & gp41 Family : Retroviridae Subfamily : Lentivirus Icosahedral symmetry Nucleocapsid Outer matrix protein (p17) Mj Major capsid protein ti (p24) Nuclear protein (p7) Diploid idrna with ihseveral copies of reverse transcriptase

HIV Structure surface transmembrane matrix protein capsid protein nucleocapsid protein RT Integrase protease

HIV Genome EARLY Accessory Genes LATE tat trans activator of transcription nef negative regulatory factor vif viral linfectivity it factor vpr viral protein R rev regulator of viral protein expression vpu viral protein U vpx HIV 2 9200 nucleotides (HIV 1): env gp160 (gp120:outer membrane part, gp41: transmembrane part) gag core proteins p55, p17 and p24 pol p66 (protease), p31,p51 (integrase/endonuclease)

Viral Replication Methods of transmission: Sexual transmission, presence of STD increases likelihood of transmission. Sharing contaminated needles (IV drug users). Transplantation of infected tissues or organs. Exposure to infected blood or bloodproducts products. Use of contaminated clotting factors by hemophiliacs. Motherto to fetus, perinatal transmission variable, dependent on viral load and mother s CD 4 count.

Viral Replication Firststep, step, HIVattaches to susceptible host cell. Site of attachment is the CD4 antigen found on a variety of cells helper T cells macrophages monocytes B cells microglial brain cells intestinal cells T cells infected later on.

HIV Life History CCR5 the co receptor HIV chemokine CD4 CCR5 CD4 CCR5 CD4 Mutant CCR5 macrophage

Virion interaction with CD4 receptor and CXCR4 co receptor

Early Phase HIV Infection In early phase HIV infection, initial viruses are M tropic. Their envelope glycoprotein gp120 is able to bind to CD4 molecules l and chemokine receptors called CCR5 found on macrophages

Late Phase HIV Infection In late phase HIV infection, most of the viruses are T tropic, having gp120 capable of binding to CD4 and CXCR4 found on T4 lymphocytes.

Retrovirus life cycle:

HIV and AIDS The cellular and immunological picture - The course of the disease

HIV Diagnostic Testing

Purpose of HIV Testing To identify asymptomatic individuals To diagnose HIV infection in those who practice high risk behavior To prevent secondary transmission Donor screening for blood & tissue products For prophylaxis, Mdi Medical management, ttreatment t For epidemiological surveillance To diagnose clinically suspected cases

Laboratory diagnosis of HIV infection Direct demonstration of infective agent - Virus isolation- virus culture - Antigen detection- P24 detection - viral nucleic acid detection- PCR Indirect demonstration of infective agent - Anti -HIV antibody detection

Initial and Supplemental HIV Tests Initial Test - Enzyme Immunoassay (EIA) - Chemiluminescent i Immunoassay (CIA) Supplemental Tests - Western blot - Indirect Immunofluorescence Assay (IFA) - Qualitative HIV-1 RNA

Spectrum of Immunologic Methods in Diagnosis of HIV Infection HIV diagnosis (Antibody/Antigen testing) Enzyme Immunoassays (EIAs) Rapid tests Western blot t(wb) Early diagnosis in infants p24 Initiation and monitoring of ART CD4 count

Enzyme Immunoassays (EIAs) Quantitative assay to measure HIV antibodies Most detect antibodies to HIV 1 and HIV 2 Antigens coated in microwells HIV Antigen / Antibody reaction is detected dby color change I t it f l fl t t f tib d t Intensity of color reflects amount of antibody present serum

After several incubation and wash steps, a color reaction occurs if HIV antibody is present An automated reader gives a measurement of optical density (presence of color) for each well

Generation of EIA Tests First Second Third *Fourth *Not US FDA approved as of 10/1/09 Uses crude viral Uses recombinant HIV Detects t IgM and IgG Detects t HIV antibodies lysate antigens or peptides in Sandwich EIA and p24 antigen

False Negatives and Positives False negative results may result from: Window period Agammaglobulinemia Seroreversion (loss of HIV antibodies due to extreme immune system destruction) in late disease Technical error Type N or O strains, or HIV 2 False positive results may result from: Autoantibodies e.g., SLE vaccines Technical error 24

Common HIV 1 or HIV 1/2 Diagnostic Algorithm

APHL/CDC HIV 1/2 Diagnostic Algorithm Template

Rapid tests Qualitative assay to detect HIV antibodies Most detect HIV 1 and HIV 2 As reliable as EIAs Advantages: 1. Quick 2. Easy to perform 3. No sophisticated instruments are required 4. Can be done on single sample Disadvantages: 1. Costly 2. Tedious if large no. samples have to be tested at one time

The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again. image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again. Tests Based on Immunochromatography h Lateral Flow Devices Determine Hema Strip OraQuick Unigold The Control HIV Antigen Sample pad Specimen Flow

Body Fluids Used for HIV Rapid Testing Serum Plasma Whole blood Oral fluids

Reading Results Positive HIV-1/2 Reactive Control Positive Negative Read results in 20 40 minutes

4 th Generation Immunochromatograpic test t for detection ti of HIV Ag/Ab Control bar (anti-hiv) p24 bar (avidin) Ab bar (rhiv Ag + synt peptides) Conjugate pad (Selenium colloid-hiv Ag/ Biotinylated anti-p24+ Selenium colloid anti-p24) B

4 th Generation Immunochromatograpic test t for detection ti of HIV Ag/Ab Control bar (anti-hiv) p24 bar (avidin) B Ab bar (rhiv Ag + synt peptides) B Conjugate pad (Selenium colloid-hiv Ag/ Biotinylated anti-p24+ Selenium colloid anti-p24) B Patient sample

Determine HIV-1/2 Ag/Ab Combo Control bar Selenium colloid Conjugate pad p24 Antigen bar Antibody bar

How Particle Agglutination Works Anti HIV antibodies bind to the antigen coated latex particles. Antigen Antibody

Proposed HIV Point of Care Algorithm HIV Diagnostic Algorithm (Rapid Test) Two Rapid Tests (A1/A2) Performed in Sequence on Blood or Oral Fluid (A1 and A2 must be different rapid tests) A1 [HIV-1 or HIV-1/2 rapid test (Blood or oral fluid)] A1+ A2 [HIV-1 or HIV 1/2 rapid test from a different manufacturer (blood)] A1- Negative for HIV-1 and dhiv2 HIV-2 antibodies* * A1+ A2+ Presumptive positive for HIV-1 or HIV-2 antibodies; requires medical follow-up for further evaluation and testing A1+ A2- Inconclusive rapid test result; requires additional testing *If using an HIV-1 only rapid test, Negative for HIV-1 antibodies only

Western Blot / Line Immunoassays Used as supplemental test for confirmation (only difficult cases) Detects antibodies to specific HIV antigens on cellulose strip

Confirmatory Tests Western Blot, Line immunoassay WB use antigens from whole virus lysates electrophoretically transferred to a membrane LIA use recombinant or synthetic HIV antigens mechanically applied on to support membrane Presence or absence of bands is scored Highly specific, Labor intensive, expensive WHO criteria- presence of at least 2 envelope bands (gp120, gp160,gp41) gp41)

HIV-1 Western Blot Antigens p = protein gp = glycoprotein Number = molecular weight

Components Used in HIV-1 Western Blot HIV Western blot Strip Color Reagent Y Y Y Enzyme Detector Antihuman IgG Antibodies Y Y Y Y YY Human HIV Antibodies (from patient serum) HIV Antigens (on Western blot)

HIV-1 and HIV-2 Gene Products & Western Blot

Interpretive Criteria for HIV-1 Western Blot Positive Control Negative Indeterminate Positive No bands: One or more bands present Not meeting positive criteria At least two of the Following bands: p24, gp41, gp120/160

Indirect immunofluorescence Can be used to detect both virus and antibody to it. Antibody detected by testing patient serum against antigen applied to a slide, incubated, washed hdand a fluorescent antibody added. Virus is detected by fixing patient cells to slide, incubating with antibody

Direct Methods of HIV diagnosis: p24 antigen detection EIA for detection of p24 antigen in serum, plasma, CSF or cell culture Can detect infection in window period, in late stage of disease,and in newborns To monitor response to anti-retroviral therapy To monitor disease progression Sensitivity is limited (only 69% in patients with AIDS and low in neonates < 1 month old) Negative test does not rule out HIV infection

Window Period Period between infection and first reliable detection of HIV by lab test. Window period varies by test and by individual. The majority of infected individuals are positive by ELISA, antigen, and/or DNA/RNA tests by 6 8 weeks after infection. 44

typical primary HIV 1 infection symptoms HIV proviral DNA symptoms window period HIV antibodies HIV viral load HIV-1 p24 antigen 0 1 2 3 4 5 6 / 2 4 6 8 10 1 infection weeks years Time following infection

Minimum Time from Infection to First Dt Detection ti of HIV 1 Markers KEY: TIME PERIOD BEFORE DETECTION TIME WHEN HIV DETECTION BY TEST IS POSSIBLE ELISA p24 DNA PCR RNA (VL) Infection 5 10 15 20 25 30 35 Detection of HIV: time (in days) after infection 46

Detection of HIV by Diagnostic Tests Symptoms p24 Antigen HIV RNA HIV Enzyme Immune Assay (EIA)* Western blot 0 1 2 3 4 5 6 7 8 9 10 Weeks Since Infection *4 th generation, Ag/Ab Combo EIA *3 rd generation, IgM-sensitive EIA *2 nd generation EIA *viral lysate EIA

Management of HIV Goal is undetectable (<48 copies/ml) HIV viral load (Assays vary on limit of detection from <75 to <20 copies/ml) Monitor the HIV viral load : 3 months once goal is achieved CD4 counts can be repeated : 6 12 months if viral lload controlled

CD4 T Lymphocyte CD4 T lymphocyte counts used for: Determining clinical prognosis Assessing criteria for antiretroviral therapy Monitoring therapy Manual and automated t methods Issues: Requires high level of technical skill for test performance and interpretation Properly maintained equipment

CD4 Cell Counts CD4 cell count measures the number of CD4 cells per cubic milliliter of blood. The CD4 count is a measure of the degree of immunocompromise and stage of HIV disease progression. The CD4 count is an important test for deciding whether ARV therapy is required and for monitoring the recovery of the immune system under treatment. 50